1. Home
  2. RLI vs BLCO Comparison

RLI vs BLCO Comparison

Compare RLI & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLI Corp. (DE)

RLI

RLI Corp. (DE)

HOLD

Current Price

$59.48

Market Cap

5.6B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.88

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLI
BLCO
Founded
1965
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.1B
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
RLI
BLCO
Price
$59.48
$16.88
Analyst Decision
Hold
Buy
Analyst Count
7
11
Target Price
$62.40
$18.45
AVG Volume (30 Days)
506.2K
373.5K
Earning Date
04-22-2026
04-29-2026
Dividend Yield
5.16%
N/A
EPS Growth
16.84
N/A
EPS
2.42
N/A
Revenue
$1,882,448,000.00
$5,101,000,000.00
Revenue This Year
N/A
$8.65
Revenue Next Year
$3.53
$5.59
P/E Ratio
$24.97
N/A
Revenue Growth
6.33
6.47
52 Week Low
$47.26
$13.77
52 Week High
$67.12
$18.92

Technical Indicators

Market Signals
Indicator
RLI
BLCO
Relative Strength Index (RSI) 36.69 44.07
Support Level $58.08 $16.84
Resistance Level $63.41 $17.20
Average True Range (ATR) 1.17 0.48
MACD -0.39 -0.13
Stochastic Oscillator 16.69 17.69

Price Performance

Historical Comparison
RLI
BLCO

About RLI RLI Corp. (DE)

RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety, and it derives a majority of its revenue from the Casualty segment.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: